Q&A With Dr. Samir Guglani, Consultant, Clinical Oncologist, and Writer

Samir guglani

Dr. Samir Guglani (MBBS, MRCP, FRCR) is a consultant clinical oncologist and a writer. He is also the founder, director, and curator of Medicine Unboxed, an annual event which uses the arts to engage health professionals and the public in conversation around medicine.

Dr. Guglani obtained his medical degree from the University College Hospital London Medical School (1995), having also completed an intercalated degree in neuroscience there.

Read more

What You Should Know: Understanding Immunotherapy Techniques for Cancer Treatment

The American Cancer Society estimated that in 2015, there were 1,658,370 new cases of cancer diagnosed in this country and some 589,430 deaths. These widespread numbers mean that whether a new doctor enters into general practice, oncology or some other specialty, they are likely to have to work with cancer patients. Because of this, a good understanding of new developments in cancer treatment is important in order to inform and educate patients fully about their potential options.

Read more

Effects of Climate Change on Human Health–And Why Student Doctors Should Care

When most student doctors take a moment from their busy schedules to think about climate change, what probably comes to mind is rising ocean levels or melting polar ice caps. What many do not think about, even in the medical profession, is the effect that climate change potentially has on human health. As many of the foremost meteorological institutions predict that the climate is only destined to become warmer in coming decades, these health effects will very likely affect doctors going into practice in the near future.
This article will take a look at several of the categories of health problems that are more vulnerable to climate change – and that could have a big impact on physicians now going into practice.
Respiratory Diseases
One of the areas in which doctors will likely feel the impact of climate change is that of respiratory diseases, particularly allergies and asthma. According to the National Institute of Environmental Health Sciences (NIEHS), this impact will happen for a number of reasons. Firstly, increases in ground-level ozone levels can trigger respiratory symptoms like inflammation of the lungs, causing a decrease in lung function and other symptoms like chest pains, coughing and congestion. Increased temperatures and carbon dioxide will also increase levels of allergens such as pollen and mold spore counts, making it more difficult for sensitive people to cope.

Read more

20 Questions : Karen M. Winkfield, MD, PhD, Radiation Oncology

Karen M. Winkfield, MD, PhD, is a radiation oncologist with Massachusetts General Hospital, and she divides her time among clinic research in health equity and hematologic malignancies, teaching as assistant professor of radiation oncology at Harvard Medical School, and a clinical practice treating patients with lymphoma, leukemia, myeloma, myelodysplastic syndrome and other blood cell dyscrasias, and breast and gynecologic malignancies.
Dr. Winkfield received her bachelor’s degree in biochemistry from Binghamton University (1997), and her PhD in pathology (2004) and MD (2005) from Duke University. She completed an internship in internal medicine at Duke and a residency in radiation oncology at Harvard. Dr. Winkfield co-founded and directs the Association of Black Radiation Oncologists, and she’s been published in numerous journals, including the Journal of Biological ChemistryJournal of the National Medical AssociationInternational Journal of Radiation Oncology – Biology – PhysicsOncologyJournal of the American Academy of Dermatology, and New England Journal of Medicine. She also currently chairs the Health Access and Training Subcommittee for the American Society For Radiation Oncology and is chair-elect of the Health Disparities Committee for the American Society of Clinical Oncology.

Read more

20 Questions: Kornelia Polyak, MD, PhD, Medical Oncologist

Kornelia Polyak, MD, PhD, is a professor of medicine in the department of medical oncology at the Dana-Farber Cancer Institute at Harvard Medical School, as well as a biomedical researcher focused on translational studies with potential clinical impact regarding human breast cancer. Dr. Polyak has been a member of the Harvard Biological and Biomedical Sciences (BBS) graduate program since 1999, and as a BBS faculty member, she has participated in teaching several graduate courses and giving talks at departmental retreats and minisymposia. She has also participated in new student recruiting events by interviewing prospective students, attending dinners/receptions, and welcoming new students. Dr. Polyak received her MD summa cum laude from Albert Szent-Gyorgyi Medical University in Szeged, Hungary (1991), and her PhD in cell biology and genetics from Weill Cornell Graduate School of Medical Sciences (1995). She was a research associate in cancer genetics at Johns Hopkins Oncology Center, Howard Hughes Medical Institute (1995-1998).

Read more

20 Questions: Erica L. Mayer, MD, MPH, Breast Oncology

Erica L. Mayer is a medical oncologist at the Susan F. Smith Center for Women’s Cancers/Dana-Farber Cancer Institute, as well as an associate physician at Brigham & Women’s Hospital and assistant professor of medicine at Harvard Medical School. She’s the faculty education coordinator for breast oncology and director of advanced fellowship in breast oncology at Dana-Farber, as well as director of clinical research at Dana-Farber and Women’s Cancer Center at Faulkner Hospital. Mayer received a bachelor’s degree in both biology and history from Williams College in Williamstown, MA, where she graduated summa cum laude (1995). She received her MD from Harvard Medical School (2000), and her MPH in clinical effectiveness from Harvard School of Public Health (2005). Dr. Mayer’s postdoctoral training included a clinical fellowship at Harvard Medical School (2000-2006), a residency in internal medicine at Brigham & Women’s Hospital (2000-2003), a chief residency in internal medicine at Faulkner Hospital (2002-2006), and clinical fellowships in both medical oncology and medicine at Dana-Farber/Partners Cancer Care and Brigham & Women’s Hospital, respectively (2003-2006).
Dr. Mayer is a member of the Massachusetts Medical Society, American Society of Clinical Oncology, Cancer and Leukemia Group B, and Translational Breast Cancer Research Consortium. She’s involved in numerous funded research projects focusing on the role of novel biologic agents in the treatment of advanced breast cancer, and she has been published in numerous peer-reviewed publications including Nature, Journal of Biological Chemistry, Clinical Breast Cancer, Journal of Clinical Oncology, American Journal of Surgery, Annals of Oncology, and Clinical Cancer Research.

Read more

20 Questions: Julie Hersch, MD



Dr. Julie Hersch, an oncologist with Kaiser Permanente Medical Center in Roseville, Calif., attended University of California, Davis, (UCD) before heading to Albert Einstein College of Medicine in New York. After, Dr. Hersch returned to California, serving her internship with UCD’s department of internal medicine, then a residency with UCD’s department of internal medicine, and finishing with a fellowship with UCD’s division of hematology/oncology.

Read more